Oncoinvent, a clinical-stage radiopharmaceutical company developing innovative treatments for solid cancers, today announced the successful enrollment of the sixth patient into the safety lead-in ...

Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced ...

In connection with the release of the results for the full year and fourth quarter 2024, Oncoinvent invites to the following events: Thursday 27 February 202507.30 CETRelease of stock exchange ...

Cell Cycle, 7, 842-7. [57] Vallon, Seidl, Blechert, Li, Gilbertz, Baumgart, Aichler, Feuchtinger, Gaertner, Bruchertseifer, Morgenstern, Walch, Senekowitsch-Schmidtke, and Essler (2012) Enhanced ...